Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S3 pseudogene 3 is a processed pseudogene located in the human genome and does not encode a functional protein[3][1][6]. It is derived from the ribosomal protein S3 gene (RPS3), which encodes a key 40S ribosomal subunit component involved in protein synthesis, DNA damage repair, and cellular stress responses[1][5]. Unlike its parental gene, RPS3P3 lacks coding potential, does not produce active ribosomal protein, and there is no evidence it participates directly in any known biological functions, therapeutic mechanisms, or disease processes. There are multiple annotated pseudogenes related to ribosomal proteins dispersed throughout the genome[1][6]. No drugs, biomarkers, or therapeutic mechanisms are associated with RPS3P3, and it is not considered a receptor, enzyme, transporter, or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3 pseudogene 3 (RPS3P3).